Recruiting

Genetic Testing

Sponsor:

Genomic Prediction Inc.

Code:

NCT04477863

Conditions

Infertility

Genetic Disease

IVF

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

Follow-up Interview

Study Details

Brief summary:

The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. A licensed genetic counselor will conduct a recorded interview.

Conditions

Infertility

Genetic Disease

IVF

Study ID

NCT04477863

Start date

Jul 11, 2020

Status verified date

Aug, 2025

Completion date

Dec 31, 2050

Anticipated

Primary completion date

Jul 11, 2050

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients indicating willingness to participate in research during informed consent to perform PGT

Exclusion Criteria:

  • Patients who opted out of participating in research during informed consent to perform PGT

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Interventions

Follow-up Interview

Non Applicable

Primary outcome measure

  • Patient perspectives on PGT [ Time Frame: 2 years ]

Central Contacts and Locations

Central contacts

Talia Metzgar, RN

(973) 529-4223Talia@genomicprediction.com

Bhavini Rana

(973) 529-4223bhavini@genomicprediction.com

Locations

Genomic Prediction Clinical Laboratory

Recruiting

North Brunswick, New Jersey, United States, 08902

Contacts

Talia Metzgar, RN

(973) 529-4223Talia@genomicprediction.com

Bhavini Rana

(973) 529-4223bhavini@genomicprediction.com

Principal Investigator:

Nathan Treff, PhD

More Information

Sponsor

Genomic Prediction Inc.

Last update posted

Aug 26, 2025

Last verified

Aug, 2025

Keywords

  • PGT
  • Follow-up

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-03. This information was provided to ClinicalTrials.gov by Genomic Prediction Inc. on 2025-08-26.